Company / Revenue
CHAMPIONS ONCOLOGY, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$50.2M
FY2025
5-year range
$32.1M / $56.9M
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $9M in FY2016 to $57M in FY2024.
Based on SEC 10-K filings.
$50M in FY2025 with a 5-year CAGR of +4.1%.
Improved from $49M to $50M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +6.9%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.1%, indicating consistent growth.
- In FY2025, revenue decreased 11.9% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.2M | -11.9% |
| FY2024 | $56.9M | +16.0% |
| FY2023 | $49.1M | +19.7% |
| FY2022 | $41.0M | +27.8% |
| FY2021 | $32.1M | -21.7% |
| FY2020 | $41.0M | +27.8% |
| FY2019 | $32.1M | +108.4% |
| FY2018 | $15.4M | +37.8% |
| FY2017 | $11.2M | +26.2% |
| FY2016 | $8.9M | -23.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026